In a report released yesterday, Allen Klee from Maxim Group maintained a Buy rating on Kaleyra (KLR), with a price target of $42.00.
The post Maxim Group Keeps a Buy Rating on Kaleyra (KLR) appeared first on Smarter Analyst.
In a report released yesterday, Allen Klee from Maxim Group maintained a ...

https://www.smarteranalyst.com/new-blurbs/maxim-group-keeps-a-buy-rating-on-kaleyra-klr/

#SmarterAnalyst

In a report released today, Elyse Greenspan from Wells Fargo maintained a Hold rating on Athene Holding (ATH), with a price target of ...
The post Athene Holding (ATH) Receives a Hold from Wells Fargo appeared first on Smarter Analyst.
In a report released today, Elyse Greenspan from Wells Fargo ...

https://www.smarteranalyst.com/new-blurbs/athene-holding-ath-receives-a-hold-from-wells-fargo/

#SmarterAnalyst

In a report released today, Chris Kotowski from Oppenheimer assigned a Hold rating to Stellus Capital (SCM). The companys shares closed last Friday ...
The post Stellus Capital (SCM) Receives a Hold from Oppenheimer appeared first on Smarter Analyst.
In a report released today, Chris Kotowski from ...

https://www.smarteranalyst.com/new-blurbs/stellus-capital-scm-receives-a-hold-from-oppenheimer-2/

#SmarterAnalyst

Raymond James analyst Brian Gesuale maintained a Buy rating on PAE (PAE) today and set a price target of $15.00.
The post PAE (PAE) Receives a Buy from Raymond James appeared first on Smarter Analyst.
Raymond James analyst Brian Gesuale maintained a Buy rating on PAE (PAE) today and set a price ...

https://www.smarteranalyst.com/new-blurbs/pae-pae-receives-a-buy-from-raymond-james-3/

#SmarterAnalyst

Raymond James analyst Robert Dodd maintained a Buy rating on Barings BDC (BBDC) today and set a price target of $12.00.
The post Raymond James Believes Barings BDC (BBDC) Wont Stop Here appeared first on Smarter Analyst.
Raymond James analyst Robert Dodd maintained a Buy rating on Barings BDC (BBDC...

https://www.smarteranalyst.com/new-blurbs/raymond-james-believes-barings-bdc-bbdc-wont-stop-here-2/

#SmarterAnalyst

Barclays analyst John Aiken maintained a Buy rating on Element Financial (ELEEF) on May 7 and set a price target of C$19.00.
The post Element Financial (ELEEF) Gets a Buy Rating from Barclays appeared first on Smarter Analyst.
Barclays analyst John Aiken maintained a Buy rating on Element Financial...

https://www.smarteranalyst.com/new-blurbs/element-financial-eleef-gets-a-buy-rating-from-barclays/

#SmarterAnalyst

Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Wayfair (W), Kellogg (K) and Edgewell Personal ...
The post Analysts Offer Insights on Consumer Goods Companies: Wayfair (W), Kellogg (K) and Edgewell Personal Care (EPC) appeared first on Smarter Analyst.
...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-consumer-goods-companies-wayfair-w-kellogg-k-and-edgewell-personal-care-epc/

#SmarterAnalyst

Analysts have been eager to weigh in on the Utilities sector with new ratings on Brookfield Infrastructure (BIP), Delek US Holdings (DK) and ...
The post Analysts Offer Insights on Utilities Companies: Brookfield Infrastructure (BIP), Delek US Holdings (DK) and Parex Resources (OtherPARXF) appeared ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-utilities-companies-brookfield-infrastructure-bip-delek-us-holdings-dk-and-parex-resources-otherparxf/

#SmarterAnalyst

Oppenheimer analyst Jay Olson assigned a Hold rating to Intercept Pharma (ICPT) yesterday and set a price target of $20.00.
The post Intercept Pharma (ICPT) Gets a Hold Rating from Oppenheimer appeared first on Smarter Analyst.
Oppenheimer analyst Jay Olson assigned a Hold rating to Intercept Pharma...

https://www.smarteranalyst.com/new-blurbs/intercept-pharma-icpt-gets-a-hold-rating-from-oppenheimer-2/

#SmarterAnalyst

Theres a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on Aon (AON), Cboe Global Markets ...
The post Analysts Offer Insights on Financial Companies: Aon (AON), Cboe Global Markets (CBOE) and Host Hotels & Resorts (HST) appeared first on Smarter Analyst.
Theres a ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-financial-companies-aon-aon-cboe-global-markets-cboe-and-host-hotels-resorts-hst/

#SmarterAnalyst

Oppenheimer analyst Bryan Blair assigned a Hold rating to AO Smith (AOS) yesterday. The companys shares closed last Tuesday at $71.
The post AO Smith (AOS) Gets a Hold Rating from Oppenheimer appeared first on Smarter Analyst.
Oppenheimer analyst Bryan Blair assigned a Hold rating to AO Smith (AOS) ...

https://www.smarteranalyst.com/new-blurbs/ao-smith-aos-gets-a-hold-rating-from-oppenheimer-7/

#SmarterAnalyst

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pacira Pharmaceuticals (PCRX) and AbbVie (ABBV). ...
The post Analysts Opinions Are Mixed on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX) and AbbVie (ABBV) appeared first on Smarter Analyst.
...

https://www.smarteranalyst.com/new-blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pacira-pharmaceuticals-pcrx-and-abbvie-abbv/

#SmarterAnalyst

In a report released yesterday, Ittai Kidron from Oppenheimer maintained a Hold rating on Arista Networks (ANET). The companys shares closed last Tuesday ...
The post Arista Networks (ANET) Receives a Rating Update from a Top Analyst appeared first on Smarter Analyst.
In a report released yesterday...

https://www.smarteranalyst.com/new-blurbs/arista-networks-anet-receives-a-rating-update-from-a-top-analyst-3/

#SmarterAnalyst

Oppenheimer analyst Bryan Blair assigned a Buy rating to Altra Industrial Motion (AIMC) yesterday and set a price target of $67.00.
The post Oppenheimer Believes Altra Industrial Motion (AIMC) Still Has Room to Grow appeared first on Smarter Analyst.
Oppenheimer analyst Bryan Blair assigned a Buy ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-believes-altra-industrial-motion-aimc-still-has-room-to-grow-2/

#SmarterAnalyst

Oppenheimer analyst Timothy Horan maintained a Buy rating on Akamai (AKAM) yesterday and set a price target of $130.00.
The post Akamai (AKAM) Gets a Buy Rating from Oppenheimer appeared first on Smarter Analyst.
Oppenheimer analyst Timothy Horan maintained a Buy rating on Akamai (AKAM) yesterday ...

https://www.smarteranalyst.com/new-blurbs/akamai-akam-gets-a-buy-rating-from-oppenheimer/

#SmarterAnalyst

Kepler Capital analyst Anna Maria Benassi maintained a Hold rating on SpareBank 1 Nord-Norge (SPXXF) on May 3 and set a price target ...
The post SpareBank 1 Nord-Norge (SPXXF) Gets a Hold Rating from Kepler Capital appeared first on Smarter Analyst.
Kepler Capital analyst Anna Maria Benassi ...

https://www.smarteranalyst.com/new-blurbs/sparebank-1-nord-norge-spxxf-gets-a-hold-rating-from-kepler-capital-5/

#SmarterAnalyst

Kepler Capital analyst Kevin Roger maintained a Buy rating on BW Offshore (BGSWF) on May 3 and set a price target of NOK65.00.
The post Kepler Capital Maintains Their Buy Rating on BW Offshore (BGSWF) appeared first on Smarter Analyst.
Kepler Capital analyst Kevin Roger maintained a Buy rating on BW...

https://www.smarteranalyst.com/new-blurbs/kepler-capital-maintains-their-buy-rating-on-bw-offshore-bgswf-3/

#SmarterAnalyst

Veoneer (VNE) received a Sell rating and a $19.00 price target from Kepler Capital analyst Alexandre Raverdy on May 3.
The post Kepler Capital Downgrades Veoneer (VNE) to Sell appeared first on Smarter Analyst.
Veoneer (VNE) received a Sell rating and a $19.00 price target from Kepler Capital ...

https://www.smarteranalyst.com/new-blurbs/kepler-capital-downgrades-veoneer-vne-to-sell-7/

#SmarterAnalyst

Kepler Capital analyst Anna Maria Benassi maintained a Buy rating on UBS Group AG (UBS) on May 3 and set a price target ...
The post UBS Group AG (UBS) Receives a Buy from Kepler Capital appeared first on Smarter Analyst.
Kepler Capital analyst Anna Maria Benassi maintained a Buy rating on UBS Group...

https://www.smarteranalyst.com/new-blurbs/ubs-group-ag-ubs-receives-a-buy-from-kepler-capital-3/

#SmarterAnalyst

Kepler Capital analyst Alexandre Raverdy downgraded Ferrari (RACE) to Hold on May 3 and set a price target of EUR185.00.
The post Ferrari (RACE) was Downgraded to a Hold Rating at Kepler Capital appeared first on Smarter Analyst.
Kepler Capital analyst Alexandre Raverdy downgraded Ferrari (RACE) to ...

https://www.smarteranalyst.com/new-blurbs/ferrari-race-was-downgraded-to-a-hold-rating-at-kepler-capital-3/

#SmarterAnalyst

Kepler Capital analyst Anna Maria Benassi maintained a Hold rating on Erste Group Bank AG (EBKDY) on May 3 and set a price ...
The post Erste Group Bank AG (EBKDY) Gets a Hold Rating from Kepler Capital appeared first on Smarter Analyst.
Kepler Capital analyst Anna Maria Benassi maintained a Hold ...

https://www.smarteranalyst.com/new-blurbs/erste-group-bank-ag-ebkdy-gets-a-hold-rating-from-kepler-capital-3/

#SmarterAnalyst

Kepler Capital analyst Anna Maria Benassi maintained a Hold rating on Deutsche Bank AG (DB) on May 3 and set a price target ...
The post Kepler Capital Sticks to Their Hold Rating for Deutsche Bank AG (DB) appeared first on Smarter Analyst.
Kepler Capital analyst Anna Maria Benassi maintained a Hold...

https://www.smarteranalyst.com/new-blurbs/kepler-capital-sticks-to-their-hold-rating-for-deutsche-bank-ag-db/

#SmarterAnalyst

In a report released yesterday, Scott Devitt from Stifel Nicolaus maintained a Buy rating on Coursera (COUR), with a price target of $54.00.
The post Coursera (COUR) Gets a Buy Rating from Stifel Nicolaus appeared first on Smarter Analyst.
In a report released yesterday, Scott Devitt from Stifel ...

https://www.smarteranalyst.com/new-blurbs/coursera-cour-gets-a-buy-rating-from-stifel-nicolaus/

#SmarterAnalyst

Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Durect (DRRX) and Invitae (NVTA) ...
The post Analysts Offer Insights on Healthcare Companies: Durect (DRRX) and Invitae (NVTA) appeared first on Smarter Analyst.
Theres a lot to be optimistic about in the ...

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-durect-drrx-and-invitae-nvta/

#SmarterAnalyst

In a report released today, Steven Lichtman from Oppenheimer assigned a Hold rating to Globus Medical (GMED), with a price target of $79.00.
The post Globus Medical (GMED) Receives a Hold from Oppenheimer appeared first on Smarter Analyst.
In a report released today, Steven Lichtman from Oppenheimer...

https://www.smarteranalyst.com/new-blurbs/globus-medical-gmed-receives-a-hold-from-oppenheimer-3/

#SmarterAnalyst

Tudor Pickering analyst Tudor Pickering reiterated a Buy rating on Pembina Pipeline (PBA) yesterday and set a price target of C$40.00.
The post Tudor Pickering Keeps a Buy Rating on Pembina Pipeline (PBA) appeared first on Smarter Analyst.
Tudor Pickering analyst Tudor Pickering reiterated a Buy ...

https://www.smarteranalyst.com/new-blurbs/tudor-pickering-keeps-a-buy-rating-on-pembina-pipeline-pba/

#SmarterAnalyst

In a report released today, Scott Berg from Needham assigned a Buy rating to Bill.com Holdings (BILL), with a price target of $170.
The post Bill.com Holdings (BILL) Receives a New Rating from a Top Analyst appeared first on Smarter Analyst.
In a report released today, Scott Berg from Needham ...

https://www.smarteranalyst.com/new-blurbs/bill-com-holdings-bill-receives-a-new-rating-from-a-top-analyst/

#SmarterAnalyst

Canaccord Genuity analyst Robert Burleson maintained a Buy rating on Laird Superfood (LSF) yesterday and set a price target of $70.00.
The post Laird Superfood (LSF) Gets a Buy Rating from Canaccord Genuity appeared first on Smarter Analyst.
Canaccord Genuity analyst Robert Burleson maintained a Buy...

https://www.smarteranalyst.com/new-blurbs/laird-superfood-lsf-gets-a-buy-rating-from-canaccord-genuity/

#SmarterAnalyst

In a report released today, William Plovanic from Canaccord Genuity maintained a Buy rating on TransMedics Group (TMDX), with a price target of ...
The post TransMedics Group (TMDX) Gets a Buy Rating from Canaccord Genuity appeared first on Smarter Analyst.
In a report released today, William ...

https://www.smarteranalyst.com/new-blurbs/transmedics-group-tmdx-gets-a-buy-rating-from-canaccord-genuity-3/

#SmarterAnalyst

Oppenheimer analyst Leland Gershell maintained a Buy rating on Agile Therapeutics (AGRX) today and set a price target of $6.00.
The post Oppenheimer Thinks Agile Therapeutics Stock is Going to Recover appeared first on Smarter Analyst.
Oppenheimer analyst Leland Gershell maintained a Buy rating on ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-thinks-agile-therapeutics-stock-is-going-to-recover/

#SmarterAnalyst